Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study
This pilot study establishes the first consensus-based MCDA criteria for Saudi Arabia, prioritizing effectiveness and drug stability over costs. It emphasizes scientific validity over price, serving as a foundation for a national value-based procurement system, though further research is needed to test the framework in healthcare tenders.
Authors
- Hana Alabdulkarim (ORCID: https://orcid.org/0000-0002-5502-8743)
- Y. Alruthia
- Mai Alsaqa’aby (ORCID: https://orcid.org/0000-0001-8369-5044)
- Omar A. Almohammed (ORCID: https://orcid.org/0000-0002-3792-4106)
- Bander Balkhi
- ABDULAALI R. ALMUTAIRI
- Mohammed Almuqbil
- Horiyah Alhajri
Institutions
- Alfaisal University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Saud University (SA)
- Saudi Center for Organ Transplantation (SA)
- King Abdullah International Medical Research Center (SA)
- National Guard Health Affairs (SA)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2026-01-01
- DOI
- https://doi.org/10.2147/ceor.s568722
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00